Menu

Filtros : "Annals of hematology" Removido: "ROCHA, VANDERSON GERALDO" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria (2025)

    Kulasekararaj, Austin; Brodsky, Robert; Schrezenmeier, Hubert; Griffin, Morag; Roeth, Alexander; Piatek, Caroline; Ogawa, Masayo; Yu, Ji; Patel, Ami S; Gualandro, Sandra Fátima Menosi

    Source: Annals of hematology. Unidade: FM

    Subjects: FÁRMACOS IMUNOSSUPRESSORES, SOBREVIDA, MORTALIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      KULASEKARARAJ, Austin et al. Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria. Annals of hematology, v. 104, n. 1, p. 81-94, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/84810. Acesso em: 02 nov. 2025.

    • APA

      Kulasekararaj, A., Brodsky, R., Schrezenmeier, H., Griffin, M., Roeth, A., Piatek, C., et al. (2025). Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria. Annals of hematology, 104( 1), 81-94. doi:10.1007/s00277-025-06193-5

    • NLM

      Kulasekararaj A, Brodsky R, Schrezenmeier H, Griffin M, Roeth A, Piatek C, Ogawa M, Yu J, Patel AS, Gualandro SFM. Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria [Internet]. Annals of hematology. 2025 ; 104( 1): 81-94.[citado 2025 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84810

    • Vancouver

      Kulasekararaj A, Brodsky R, Schrezenmeier H, Griffin M, Roeth A, Piatek C, Ogawa M, Yu J, Patel AS, Gualandro SFM. Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria [Internet]. Annals of hematology. 2025 ; 104( 1): 81-94.[citado 2025 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84810

  • Artigo de periodico

    Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia (2022)

    Saldanha, Artur; Orsi, Fernanda A. ; Okazaki, Erica; Rothschild, Cynthia; Prestes, Paula; Stefanello, Bianca; Alves, Lucas; Rocha, Vanderson; Villaca, Paula

    Source: Annals of hematology. Unidade: FM

    Subjects: TROMBOCITOPENIA, SEGURANÇA DO PACIENTE, ESPLENECTOMIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SALDANHA, Artur et al. Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia. Annals of hematology, v. 101, n. 12, p. 2781-2784, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50396. Acesso em: 02 nov. 2025.

    • APA

      Saldanha, A., Orsi, F. A., Okazaki, E., Rothschild, C., Prestes, P., Stefanello, B., et al. (2022). Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia. Annals of hematology, 101( 12), 2781-2784. doi:10.1007/s00277-022-04985-7

    • NLM

      Saldanha A, Orsi FA, Okazaki E, Rothschild C, Prestes P, Stefanello B, Alves L, Rocha V, Villaca P. Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia [Internet]. Annals of hematology. 2022 ; 101( 12): 2781-2784.[citado 2025 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50396

    • Vancouver

      Saldanha A, Orsi FA, Okazaki E, Rothschild C, Prestes P, Stefanello B, Alves L, Rocha V, Villaca P. Safety and efficacy of splenectomy for the treatment of chronic immune thrombocytopenia [Internet]. Annals of hematology. 2022 ; 101( 12): 2781-2784.[citado 2025 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50396
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025